Authors

Mohamed Natheem

Centralized Monitoring Assistant, IQVIA

Associate product and strategy director, global commercial offerings, IQVIA. He previously worked as a senior consultant in EMEA thought leadership at the company.

Janice MacLennan is CEO of Nmblr, the Biopharma and MedTech collaborative strategy platform. With over 30 years’ experience helping Biopharma and Medical Device companies tackle complex commercial challenges and develop winning strategies, she brings deep industry insight and personal passion to her work. Janice has dedicated her career to supporting the delivery of breakthrough therapies through consultancy partnerships with big and mid-sized companies across the globe. At Nmblr, she leads efforts to humanize strategy - empowering teams to align, adapt, and move as one to make better decisions and ensure innovations are delivered successfully, and to a receptive market.

Kris Kaneta

Chief product and innovation officer at Norstella. He oversees the overall strategy and development of Norstella’s product portfolio. Kaneta works closely across each brand’s leadership team to direct the product lifecycle for all data, workflow, and SaaS solutions.

Previously, he served as the chief product officer for MMIT, leading product development in support of client’s market access and drug commercialization objectives. He also served as the chief marketing officer for TeleTracking technologies, and has held leadership positions with GE HealthCare, JPMorgan Chase, and Wells Fargo.

Kaneta has an MBA from Duke University with a concentration in decision sciences, and a bachelor’s degree in economics from Illinois Wesleyan University.

Matthew Montes de Oca

Matthew Montes de Oca, PharmD, is Chief Compliance and Clinical Officer at Strive Pharmacy. With more than 10 years of pharmacy leadership experience and over four years at Strive, he oversees regulatory compliance, clinical operations, and production standards. A PharmD graduate of Pacific University, Matthew serves on the Alliance for Pharmacy Compounding Board of Directors and is engaged in industry leadership and policy discussions.

Chief strategy officer with Marken UPS Healthcare Precision Logistics. Bell joined legacy Marken in 2003. He is a licensed US Customs Broker and a certified customs specialist with more than 26 years of experience in the life science logistics and temperature control field.

Bell is responsible for leading the strategy, marketing, and pricing teams at Marken, UPS Healthcare Precision Logistics, with a focus on finding new ways to innovate, optimize, and solve clients’ greatest challenges. He has served as a liaison between clients, customs, and the alphabet soup of regulatory agencies to ensure the maximum level of compliance with trade laws and regulations.

As regulatory scrutiny continues to focus on the temperature-controlled supply chain, Bell’s expertise with thermoregulating packaging solutions and temperature logging devices has been critical to meeting the requirements of the recently updated Good Distribution Practices for pharmaceutical transport and similar guidelines.

A product and strategy leader with 17 years of experience in market research, consulting and product development. As director, Agentic AI, he leads development and commercial strategy of Agentic AI solutions layered across IQVIA’s gold standard syndicated data assets. With over 11 years at IQVIA, he drives incremental value to customers through business strategy, product development, and AI-powered solutions and data-driven insights. His responsibilities include leading product development roadmaps and implementing pricing and go-to-market strategies for next-generation analytics solutions.

Noël Theodosiou

A strategic advisor to visionary leaders in the life sciences. As Principal and CEO of Luminous, she helps innovators bridge the gap between lab and life. Too often, promising biomedical innovations fail to perform as expected in the market—not because they lack efficacy, but because they overlook the realities of patients’ lives. Noël helps companies address this gap by surfacing patient voices and revealing insights that highlight lived experiences.

Kevin Ampeh

Principal, integrated research, IQVIA. Ampeh has spent 9-plus years in the life sciences industry serving as a partner to global pharmaceutical and biotech clients across primary, market research, consulting and real-world data.

Sophia Goeppinger

Sophia Goeppinger is a founding venture fellow at Vianti Capital, helping build a biotech venture fund and evaluating investments from peri-clinical to Phase II. Beyond her work at Vianti, she focuses on SpaceBio commercialization, including funding, regulation, and the ecosystem needed to turn science into biopharma applications. Goeppinger is also a business angel investor in deep tech, with a focus on space tech.

Previously, she worked as a consultant at McKinsey & Company, advising pharmaceutical firms and biotechs on commercial strategy, market access, and due diligence. Goeppinger also worked with AIRNA Therapeutics and Roche Pharma.

She holds a Master of Public Health from Harvard T.H. Chan School and a Master’s in Strategy and International Management from the University of St. Gallen, including studies at Columbia Business School. Goeppinger graduated at the top of her class in both graduate programs and earned her bachelor’s at ESCP Business School as valedictorian. Her research on the US healthcare system won the ICIS Best Overall Paper Award.

Senior vice president of medicine and regulatory, U.S., at Boehringer Ingelheim. In her role, Clerisme-Beaty oversees medical strategy for an organization of more than 1,000 employees

Prior to joining Boehringer, Clerisme-Beaty was an assistant professor at Johns Hopkins University, where she completed advanced training in pulmonary critical care medicine. Her academic and clinical background informs a holistic approach to chronic disease management, emphasizing multidisciplinary, integrated solutions for complex conditions such as obesity and diabetes.